Diamonds and Dogs
9/23/14Galmed Pharmaceuticals Ltd. (GLMD)
Galmed is trading in the green today, up 43.21% to $9.28. The pharmaceutical company which focuses on liver diseases and cholesterol gallstones saw its shares jump after news that the FDA approved a fast track designation of their drug, Aramchol. The fast track designation means that the FDA will expedite its review of Aramchol, which treats Non-Alcoholic Steato-Hepatitis (NASH). There are currently no drugs to treat NASH, and Galmed expects to start its Phase IIb trials later this year. Shares of Galmed climbed as high as $11.48 today, but still remain under their 52-week high of $18.73.
Ascena Retail Group Inc. (ASNA)
Ascena Retail is scaring its investors today, down 16.70% to $13.77. The apparel retailer for women and teens saw its shares plummet after announcing a decline in earnings year-over-year. For the fourth quarter Ascena management reported a net income of $15.7 million or $0.10 per share. Last year, net income came in at $29.8 million or $0.19 per share. The company also released its full year earnings guidance at $0.90-$1.00 per shares, which is well below the analysts' estimates of $1.24 per share. Ascena stated that decline was due to "challenging tween market conditions." Shares of Ascena hit a new 52-week low of $13.60 intraday.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.